Recruitment

Recruitment Status
Completed
Estimated Enrollment
32

Summary

Conditions
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Locations

Indianapolis, Indiana, 46202
Indianapolis, Indiana, 46202

Tracking Information

NCT #
NCT02078102
Collaborators
National Cancer Institute (NCI)
Investigators
  • Principal Investigator: Sherif Farag, M.D., Ph.D. Indiana University
  • Sherif Farag, M.D., Ph.D. Indiana University